AOD9604 (2mg / 5mg / 10mg) appears in Metabolic Research catalogs for qualified buyers who need specification, COA, and RUO clarity—AOD9604 COA and Batch Review Notes summarizes key checks.
AOD9604 is a synthetic peptide analog derived from the C-terminal region of human growth hormone. It is used in laboratory research on lipid-metabolism signaling, GH-fragment structure-activity relationships, and peptide pathways involved in metabolic regulation.
Early patent and academic literature positioned AOD9604 analogs as tools for dissecting GH fragment biology separate from IGF-1 mediated growth signaling. AOD9604 corresponds to a modified fragment of the GH polypeptide C-terminal region studied for lipolytic signaling in adipocyte models without full GH receptor activation.
Research literature examines β3-adrenergic pathway cross-talk and fat-cell lipolysis markers in vitro when adipocyte lines are exposed to fragment analogs. Glycerol release assays, adipocyte differentiation timelines, and receptor-binding competition experiments appear frequently in fragment-peptide research papers.
Janoshik records for AOD9604, when listed at sulanpeptide.vip/coa, should be verified by task number and unique key before sample release. COA review: Match COA product name, lot, test date, and HPLC purity to vial labels for AOD9604.
Cross-check CAS 221231-10-3 and purity target ≥ 99.0%; archive approved PDFs with internal sample IDs.
Catalog identifiers for AOD9604: CAS 221231-10-3, Formula: C78H123N23O23S2. MW 1815.1 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Request method details on AOD9604 COA if purity is reported without chromatogram context.
Migration and receptor assays for AOD9604 are sensitive to degradation—confirm lot purity before release.
Chromatographic context on AOD9604 COA documents matters when purity is near your laboratory cutoff. Request integration traces or method summary if the PDF lists only a numeric HPLC result without column or gradient details. Archive AOD9604 COA PDFs using filenames tied to internal sample IDs (for example LAB-2026-0042_COA.pdf). Link reconstitution logs and aliquot records to the same ID chain so audits retrieve documentation in one step.
Janoshik-verified AOD9604 batches listed at sulanpeptide.vip/coa add third-party confirmation when task number and unique key validate successfully. Failed verification should trigger quarantine until the supplier clarifies batch status. Migration and signaling assays using AOD9604 are sensitive to oxidized or aggregated peptide. Lot release should include visual inspection (White Lyophilized Powder) plus COA approval—not catalog marketing text alone.
COA review for AOD9604 starts with identity: product name, lot, and specification (2mg / 5mg / 10mg) must match the vial label character-for-character. QA teams then confirm CAS 221231-10-3 and purity target ≥ 99.0% against internal release thresholds before material enters cell or animal workflows.
Migration and signaling assays using AOD9604 are sensitive to oxidized or aggregated peptide. Lot release should include visual inspection (White Lyophilized Powder) plus COA approval—not catalog marketing text alone. COA review for AOD9604 starts with identity: product name, lot, and specification (2mg / 5mg / 10mg) must match the vial label character-for-character. QA teams then confirm CAS 221231-10-3 and purity target ≥ 99.0% against internal release thresholds before material enters cell or animal workflows.
Janoshik-verified AOD9604 batches listed at sulanpeptide.vip/coa add third-party confirmation when task number and unique key validate successfully. Failed verification should trigger quarantine until the supplier clarifies batch status.
AOD9604 from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.